MeSH D007239 - infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D007239:
Infections
D000069578:Waterborne diseases
0 Companies
0 Drugs
Success rate
D000079263:Vaccine-preventable diseases
0 Companies
0 Drugs
Success rate
D000079426:Vector borne diseases
0 Companies
0 Drugs
Success rate
D000085343:Latent infection
0 Companies
0 Drugs
Success rate
D000088562:Persistent infection
0 Companies
0 Drugs
Success rate
D000785:Infected aneurysm
0 Companies
0 Drugs
Success rate
D001170:Infectious arthritis
D001423:Bacterial infections and mycoses
D001850:Infectious bone diseases
D002494:Central nervous system infections
D003141:Communicable diseases
D003428:Cross infection
D005490:Focal infection
0 Companies
0 Drugs
Success rate
D005891:Gingivitis
0 Companies
0 Drugs
Success rate
D006520:Animal hepatitis
0 Companies
0 Drugs
Success rate
D007757:Laboratory infection
0 Companies
0 Drugs
Success rate
D009894:Opportunistic infections
0 Companies
0 Drugs
Success rate
D010272:Parasitic diseases
0 Companies
0 Drugs
Success rate
D011251:Infectious pregnancy complications
D012141:Respiratory tract infections
D012749:Sexually transmitted diseases
0 Companies
0 Drugs
Success rate
D012874:Infectious skin diseases
D013492:Suppuration
0 Companies
0 Drugs
Success rate
D014115:Toxemia
0 Companies
0 Drugs
Success rate
D014552:Urinary tract infections
D014777:Virus diseases
D014946:Wound infection
D015047:Zoonoses
0 Companies
0 Drugs
Success rate
D015817:Eye infections
0 Companies
0 Drugs
Success rate
D016459:Prosthesis-related infections
0 Companies
0 Drugs
Success rate
D017714:Community-acquired infections
D018461:Soft tissue infections
D018805:Sepsis
D031261:Poult enteritis mortality syndrome
0 Companies
0 Drugs
Success rate
D034161:Pelvic infection
D053821:Cardiovascular infections
0 Companies
0 Drugs
Success rate
D055499:Catheter-related infections
0 Companies
0 Drugs
Success rate
D058345:Asymptomatic infections
0 Companies
0 Drugs
Success rate
D059413:Intraabdominal infections
D060085:Coinfection
0 Companies
0 Drugs
Success rate
D060737:Reproductive tract infections
0 Companies
0 Drugs
Success rate
D000093742:Breakthrough infections
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| PAION | Eravacycline | Xerava | 2018-09-20 |
Clinical Trials
Historical Success Rate
Phase 1
71%69/97
Phase 2
60%62/104
Phase 3
50%72/144
Approved: 1Overall Success rate: 21%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use